Anti-TNBC agent-9
Product Specifications
Target
Apoptosis, Bcl-2 Family, Cadherin, MMP
Related Pathways
Cytoskeletal Signaling, Proteases/Proteasome, Apoptosis
Bioactivity
Anti-TNBC agent-9 (Compound 3as) is an anticancer agent used for treating triple-negative breast cancer (TNBC) . It exhibits significant inhibitory activity against MDA-MB-453 cells, with an IC50 value of 8.5 μM. Anti-TNBC agent-9 impedes tumor cell migration by upregulating E-cadherin and downregulating N-cadherin, matrix metalloproteinase 2 (MMP2), and MMP9. Additionally, it inhibits tumor cell proliferation by inducing apoptosis, achieved through the increased expression of pro-apoptotic protein BAX and decreased expression of anti-apoptotic protein BCL-2.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2931046-01 20 µg
Recombinant Caulobacter sp. Large-conductance mechanosensitive channel (mscL)
Sign In for Pricing
View Details